Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Horm Behav. 2011 Feb 18;59(4):528–535. doi: 10.1016/j.yhbeh.2011.02.002

Figure 3.

Figure 3

Mean ± SEM rates of anxiety-like behavior in dominant females and subordinate females with either an l/l or s-variant 5HTT genotype during the placebo (open bar), estradiol (hatched bar), corticotropin releasing-hormone receptor analogue (CRHA; grey bar), and combined estradiol and CRHA (closed bar) treatments. Different letters among the four study groups reflect significantly different rates of anxiety-like behavior collapsed across treatment conditions. The asterisk indicates estradiol replacement significantly attenuated anxiety-like behaviors in those study groups.